Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

December 28, 2024

Study Completion Date

January 30, 2025

Conditions
Hyponatremia With Excess Extracellular Fluid VolumeCirrhosis, Liver
Interventions
DRUG

Albumin treatment

one dose per day of a 40g albumin g/l gram(s)/litre for 10 days. resolution of hyponatremia, defined as an increase in serum sodium of more than 5 mEq/L with a final value \> 130 mEq/L, maintained for at least 48 consecutive hours during the 10-day treatment period

Trial Locations (3)

08036

Hospital Clinic de Barcelona, Barcelona

Unknown

Hospital Moises Broggi, Barcelona

08208

Hospital Parc Taulí, Sabadell

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT03941405 - Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT) | Biotech Hunter | Biotech Hunter